Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cipher Pharmaceuticals (CPHRF)
OTHER OTC:CPHRF
RESEARCH TOOLSreports
Holding CPHRF?
Track your performance easily
CPHRF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.50 - $14.60
Previous Close$11.42
Volume22.32K
Average Volume (3M)30.67K
Market Cap
$280.93M
Enterprise Value$252.07M
Total Cash (Recent Filing)$39.83M
Total Debt (Recent Filing)$353.00K
Price to Earnings (P/E)12.3
Beta-0.51
Next Earnings
Nov 07, 2024EPS Estimate
$0.19Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.93
Shares Outstanding25,588,552
10 Day Avg. Volume81,462
30 Day Avg. Volume30,672
Standard Deviation0.19
R-Squared0.05
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)3.62
Price to Sales (P/S)13.91
Price to Cash Flow (P/CF)30.50
P/FCF Ratio32.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.91
Enterprise Value/Gross Profit14.75
Enterprise Value/Ebitda15.14
Forecast
1Y Price Target
$11.74Price Target Upside6.73% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cipher Pharmaceuticals News
PremiumCompany Announcements
Cipher Pharma Reports Moberg’s Study Setback
PremiumCompany Announcements
Cipher Pharmaceuticals Maintains Solid Q2 Performance
PremiumCompany Announcements
Cipher Pharmaceuticals Announces Q2 2024 Earnings Call
PremiumCompany Announcements
Cipher Pharmaceuticals Buys Dermatology Brand for $89.5M
PremiumCompany Announcements
Cipher Pharmaceuticals Shareholders Approve All Resolutions
Options Prices
Currently, No data available
---
Ownership Overview
48.42% Insiders
0.90% Mutual Funds
0.83% Other Institutional Investors
49.86% Public Companies and
Individual Investors
CPHRF FAQ
What was Cipher Pharmaceuticals’s price range in the past 12 months?
Cipher Pharmaceuticals lowest stock price was $2.50 and its highest was $14.60 in the past 12 months.
What is Cipher Pharmaceuticals’s market cap?
Currently, no data Available
When is Cipher Pharmaceuticals’s upcoming earnings report date?
Cipher Pharmaceuticals’s upcoming earnings report date is Nov 07, 2024 which is in 48 days.
How were Cipher Pharmaceuticals’s earnings last quarter?
Cipher Pharmaceuticals released its earnings results on Aug 08, 2024. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.117 by $0.003.
Is Cipher Pharmaceuticals overvalued?
According to Wall Street analysts Cipher Pharmaceuticals’s price is currently Undervalued.
Does Cipher Pharmaceuticals pay dividends?
Cipher Pharmaceuticals does not currently pay dividends.
What is Cipher Pharmaceuticals’s EPS estimate?
Cipher Pharmaceuticals’s EPS estimate is $0.19.
How many shares outstanding does Cipher Pharmaceuticals have?
Cipher Pharmaceuticals has 25,588,552 shares outstanding.
What happened to Cipher Pharmaceuticals’s price movement after its last earnings report?
Cipher Pharmaceuticals reported an EPS of $0.12 in its last earnings report, beating expectations of $0.117. Following the earnings report the stock price went up 6.478%.
Which hedge fund is a major shareholder of Cipher Pharmaceuticals?
Currently, no hedge funds are holding shares in CPHRF
---
Cipher Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$11.74 (6.73% Upside)
$11.74 (6.73% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
245.90%
12-Months-Change
Fundamentals
Return on Equity
28.43%
Trailing 12-Months
Asset Growth
16.50%
Trailing 12-Months
Company Description
Cipher Pharmaceuticals
Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products. Its products include dermatology, hospital acute care, and out-licensed products. The company was founded in 2000 and is headquartered in Oakville, Canada.
---
CPHRF Earnings Call
Q2 2024
0:00 / 0:00
---
CPHRF Stock 12 Month Forecast
Average Price Target
$11.74
▲(6.73% Upside)
Technical Analysis
Best Analysts Covering CPHRF
1 Year
1 Year Success Rate
6/6 ratings generated profit
1 Year Average Return
+45.17%
reiterated a buy rating 4 days ago
Copying Justin Keywood's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +45.17% per trade.
---